Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.29 -0.15 (-2.33%) Market Cap: 950.41 Mil Enterprise Value: 791.33 Mil PE Ratio: 0 PB Ratio: 4.25 GF Score: 78/100

Q1 2024 Adaptive Biotechnologies Corp Earnings Call Transcript

May 07, 2024 / 08:30PM GMT
Release Date Price: $3.11 (-3.42%)
Operator

Good day, and thank you for standing by, and welcome to the Adaptive Biotechnologies First Quarter 2024 earnings call. Please note, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Karina Calzadilla, Head of Investor Relations. Please go ahead.

Karina Calzadilla
Adaptive Biotechnologies Corp. - IR

Thank you, Cory, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies First Quarter 2024 earnings conference call. Earlier today, we issued a press release reporting adaptive financial results for the first quarter of 20 for the press release is available at www.adoptivebiotech.com. We are conducting a live webcast of this call and will be referencing a slide presentation that has been posted to the Investor section in our corporate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot